초록 ▼

This disclosure provides an improved system for culturing human pluripotent stem cells. Traditionally, pluripotent stem cells are cultured on a layer of feeder cells (such as mouse embryonic fibroblasts) to prevent them from differentiating. In the system described here, the role of feeder cells is

This disclosure provides an improved system for culturing human pluripotent stem cells. Traditionally, pluripotent stem cells are cultured on a layer of feeder cells (such as mouse embryonic fibroblasts) to prevent them from differentiating. In the system described here, the role of feeder cells is replaced by components added to the culture environment that support rapid proliferation without differentiation. Effective features are a suitable support structure for the cells, and an effective medium that can be added fresh to the culture without being preconditioned by another cell type. Culturing human embryonic stem cells in fresh medium according to this invention causes the cells to expand surprisingly rapidly, while retaining the ability to differentiate into cells representing all three embryonic germ layers. This new culture system allows for bulk proliferation of pPS cells for commercial production of important products for use in drug screening and human therapy.

대표청구항 ▼

The invention claimed is: 1. A method for proliferating human embryonic: stem (hES) cells, comprising culturing hES cells in the presence of an extracellular matrix in a medium that comprises a fibroblast growth factor at a concentration of at least 40 ng/mL; wherein the culture is essentially free

The invention claimed is: 1. A method for proliferating human embryonic: stem (hES) cells, comprising culturing hES cells in the presence of an extracellular matrix in a medium that comprises a fibroblast growth factor at a concentration of at least 40 ng/mL; wherein the culture is essentially free of feeder cells. 2. The method of claim 1, wherein the medium also contains nucleosides or nucleotides. 3. The method of claim 1, wherein the medium also contains insulin. 4. The method of claim 1, wherein the medium also contains transferrin. 5. The method of claim 1, wherein the medium also contains β-mercaptoethanol. 6. The method of claim 1, wherein the medium contains only human protein. 7. The method of claim 1, wherein the fibroblast growth factor is basic fibroblast growth factor (bFGF). 8. The method of claim 7, wherein the bFGF is recombinant human bFGF. 9. The method of claim 1, wherein the medium also contains stem cell factor. 10. The method of claim 1, wherein the medium also contains Flt3 ligand. 11. The method of claim 1, wherein the medium is non-conditioned. 12. The method of claim 1, wherein the extracellular matrix comprises reconstituted basement membrane from Engelbreth-Holm-Swarm tumor cells, laminin, fibronectin, proteoglycan, or entactin.